I agree that very little value or no value for can
Post# of 148278
(Total Views: 200)
Posted On: 03/22/2019 9:59:11 PM
I agree that very little value or no value for cancer has been realized in the share price. Other than a short spike to $.58 this stock hasn’t moved much over the past few months even with several positive PRs. That seems a little crazy as other biotechs jump 100s of percent in a day based on positive results in early trials.
IMO as long as the science/leronlimab continue to display positive results the ‘slight risk’ of any negative outcome with this stock/my investment is zilch. Although the way the share price reacts to positive news, I wouldn’t be the least bit shocked if mediocre or bad cancer results sunk it significantly.....I 100% believe we will have positive results, just saying that is what I would expect even though the share price has not realized any value for said cancer potential.
IMO as long as the science/leronlimab continue to display positive results the ‘slight risk’ of any negative outcome with this stock/my investment is zilch. Although the way the share price reacts to positive news, I wouldn’t be the least bit shocked if mediocre or bad cancer results sunk it significantly.....I 100% believe we will have positive results, just saying that is what I would expect even though the share price has not realized any value for said cancer potential.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼